Aché Laboratories successfully implements GS1 standards to ensure traceability

In today’s healthcare industry, it is essential for companies to remain competitive.

With this in mind, Aché Laboratories considers innovation to be an important part of its growth strategy— one that is consistently executed.

Aché’s decision to implement the drug traceability project at its laboratory in 2018 was based on Brazilian regulatory requirements and the growing global demand from consumer markets. And considering the opportunity to innovate, Aché accepted this challenge.

Why was implementing traceability a challenge?

First, there had not been a similar drug traceability regulation in Brazil before, so benchmarking results were not available to help the company better understand the magnitude of the implementation. Rather, Aché had to start from “zero”—creating internal processes, developing production-line coding equipment, working to involve and integrate several departments of the company, training the team and much more.